BioCentury | Dec 12, 2011
Company News

ChemBridge, Enamine, Galapagos, InterBioScreen Ltd. deal

...service division added 350,000 new compounds to its screening library through new supply agreements with ChemBridge...
...now has over 900,000 unique chemical compounds in its screening platform. Details were not disclosed. ChemBridge Corp....
BioCentury | Feb 21, 2011
Company News

ChemBridge, Evotec deal

...ChemBridge granted Evotec rights to include 110,000 compounds from the ChemBridge Library Collection in Evotec's screening...
...option to mutually extend the deal to include additional compounds. Financial terms were not disclosed. ChemBridge Corp....
BioCentury | Sep 25, 2006
Company News

ChemBridge, AstraZeneca deal

...ChemBridge and its spin-off ChemBridge Research Laboratories Inc. will provide chemistry services to AZN for the...
...chemistry services to AZN for the discovery of small molecules. Further terms were not disclosed. ChemBridge Corp....
BioCentury | Jun 20, 2005
Company News

ChemBridge Research, Trimeris deal

...to discover and develop oral small molecule inhibitors of two HIV targets: gp41 and gp120. ChemBridge...
...will supply medicinal chemistry services, and TRMS will be responsible for development, manufacturing and commercialization. ChemBridge...
BioCentury | Jun 14, 2005
Company News

Trimeris, ChemBridge HIV deal

...TRMS and ChemBridge (San Diego, Calif.) partnered to discover and develop oral small molecule inhibitors of...
...to discover and develop oral small molecule inhibitors of two HIV targets: gp41 and gp120. ChemBridge...
...will supply medicinal chemistry services, and TRMS will be responsible for development, manufacturing and commercialization. ChemBridge...
BioCentury | May 9, 2005
Company News

ChemBridge Research, St. Jude Children's Research Hospital Inc. deal

...ChemBridge Research and the hospital extended their cancer deal under which ChemBridge Research is using medicinal...
...against targets identified by St. Jude. The targets are related to anaplastic lymphoma kinase (ALK). ChemBridge...
BioCentury | Mar 7, 2005
Company News

UCB, Chembridge Corp. deal

...for UCB's neurology discovery efforts. Chembridge will receive research funding. UCB Group (Euronext:UCB), Brussels, Belgium Chembridge Corp....
BioCentury | Dec 13, 2004
Company News

ChemBridge Corp., Merck deal

...The companies expanded and extended for five years a 2001 deal under which ChemBridge is developing...
...chemistry libraries for use in MRK's drug discovery. The deal is now extended through 2009. ChemBridge Corp....
BioCentury | Jun 7, 2004
Company News

ChemBridge Research Laboratories LLC, Eisai deal

...payment was triggered by Eisai validating ChemBridge Research's preclinical compounds against an undisclosed GPCR target. ChemBridge...
BioCentury | Feb 16, 2004
Company News

ChemBridge, Merck KGaA, Pfizer deal

...The partners extended until 2008 a 2002 deal under which Chembridge spin-off ChemBridge Research Laboratories LLC...
...of the deal to include medicinal chemistry support for Pfizer Global Research and Development. Separately, ChemBridge...
...collaboration with MRK to develop multiple series of focused libraries for high throughput medicinal chemistry. ChemBridge Corp....
Items per page:
1 - 10 of 33
BioCentury | Dec 12, 2011
Company News

ChemBridge, Enamine, Galapagos, InterBioScreen Ltd. deal

...service division added 350,000 new compounds to its screening library through new supply agreements with ChemBridge...
...now has over 900,000 unique chemical compounds in its screening platform. Details were not disclosed. ChemBridge Corp....
BioCentury | Feb 21, 2011
Company News

ChemBridge, Evotec deal

...ChemBridge granted Evotec rights to include 110,000 compounds from the ChemBridge Library Collection in Evotec's screening...
...option to mutually extend the deal to include additional compounds. Financial terms were not disclosed. ChemBridge Corp....
BioCentury | Sep 25, 2006
Company News

ChemBridge, AstraZeneca deal

...ChemBridge and its spin-off ChemBridge Research Laboratories Inc. will provide chemistry services to AZN for the...
...chemistry services to AZN for the discovery of small molecules. Further terms were not disclosed. ChemBridge Corp....
BioCentury | Jun 20, 2005
Company News

ChemBridge Research, Trimeris deal

...to discover and develop oral small molecule inhibitors of two HIV targets: gp41 and gp120. ChemBridge...
...will supply medicinal chemistry services, and TRMS will be responsible for development, manufacturing and commercialization. ChemBridge...
BioCentury | Jun 14, 2005
Company News

Trimeris, ChemBridge HIV deal

...TRMS and ChemBridge (San Diego, Calif.) partnered to discover and develop oral small molecule inhibitors of...
...to discover and develop oral small molecule inhibitors of two HIV targets: gp41 and gp120. ChemBridge...
...will supply medicinal chemistry services, and TRMS will be responsible for development, manufacturing and commercialization. ChemBridge...
BioCentury | May 9, 2005
Company News

ChemBridge Research, St. Jude Children's Research Hospital Inc. deal

...ChemBridge Research and the hospital extended their cancer deal under which ChemBridge Research is using medicinal...
...against targets identified by St. Jude. The targets are related to anaplastic lymphoma kinase (ALK). ChemBridge...
BioCentury | Mar 7, 2005
Company News

UCB, Chembridge Corp. deal

...for UCB's neurology discovery efforts. Chembridge will receive research funding. UCB Group (Euronext:UCB), Brussels, Belgium Chembridge Corp....
BioCentury | Dec 13, 2004
Company News

ChemBridge Corp., Merck deal

...The companies expanded and extended for five years a 2001 deal under which ChemBridge is developing...
...chemistry libraries for use in MRK's drug discovery. The deal is now extended through 2009. ChemBridge Corp....
BioCentury | Jun 7, 2004
Company News

ChemBridge Research Laboratories LLC, Eisai deal

...payment was triggered by Eisai validating ChemBridge Research's preclinical compounds against an undisclosed GPCR target. ChemBridge...
BioCentury | Feb 16, 2004
Company News

ChemBridge, Merck KGaA, Pfizer deal

...The partners extended until 2008 a 2002 deal under which Chembridge spin-off ChemBridge Research Laboratories LLC...
...of the deal to include medicinal chemistry support for Pfizer Global Research and Development. Separately, ChemBridge...
...collaboration with MRK to develop multiple series of focused libraries for high throughput medicinal chemistry. ChemBridge Corp....
Items per page:
1 - 10 of 33